Morgan Stanley Keeps a Buy Rating on Biogen (BIIB)

Retrieved on: 2021-04-19 18:44:18

Tags for this article:

Click the tags to see associated articles and topics

Morgan Stanley Keeps a Buy Rating on Biogen (BIIB). View article details on hiswai:

Excerpt

Morgan Stanley analyst Matthew Harrison maintained a Buy rating on Biogen (BIIB) today and set a price target of $343.00. The company's shares ...

Article found on: www.smarteranalyst.com